Cite
Reduced growth rate accompanied by aberrant epidermal growth factor signaling in drug resistant human breast cancer cells.
MLA
Wosikowski, K., et al. “Reduced Growth Rate Accompanied by Aberrant Epidermal Growth Factor Signaling in Drug Resistant Human Breast Cancer Cells.” Biochimica et Biophysica Acta, vol. 1497, no. 2, July 2000, pp. 215–26. EBSCOhost, https://doi.org/10.1016/s0167-4889(00)00062-8.
APA
Wosikowski, K., Silverman, J. A., Bishop, P., Mendelsohn, J., & Bates, S. E. (2000). Reduced growth rate accompanied by aberrant epidermal growth factor signaling in drug resistant human breast cancer cells. Biochimica et Biophysica Acta, 1497(2), 215–226. https://doi.org/10.1016/s0167-4889(00)00062-8
Chicago
Wosikowski, K, J A Silverman, P Bishop, J Mendelsohn, and S E Bates. 2000. “Reduced Growth Rate Accompanied by Aberrant Epidermal Growth Factor Signaling in Drug Resistant Human Breast Cancer Cells.” Biochimica et Biophysica Acta 1497 (2): 215–26. doi:10.1016/s0167-4889(00)00062-8.